PANACEABIO — Panacea Biotec Share News
0.000.00%
- IN₹19.08bn
- IN₹17.91bn
- IN₹6.40bn
Brief: Panacea Biotec Postpones EGM
Brief: India's Panacea Biotec Dec Qtr Consol Net Loss After Tax From Continuing Operations Widens
Brief: Panacea Biotec Completes Transfer Of Pharmaceuticals Business To Its Unit
Brief: Panacea Biotec Gets $24.32 Mln Award Of Pentavalent Vaccine From U.N. Agencies
Brief: India's Panacea Biotec Sept-Qtr Consol Net Loss After Tax Widens
Brief: India's Panacea Biotec June-Qtr Consol Net Loss After Tax Narrows
Brief: Panacea Biotec Gets Azacitidine USFDA Approval For U.S. Market
India's Panacea Biotec surges as IndiaRF will invest up to $144 mln in co
Brief: Panacea Biotec Says India Resurgence Fund To Invest Up To $144 Mln In Co
Brief: Panacea Biotec Approves One Time Settlement With Consortium Of Lenders Of Co
Brief: Panacea Biotec To Consider Raising Of Funds
Brief: India's Panacea Biotec Posts Dec-Qtr Loss
Brief: India's Panacea Biotec Posts Sept-Qtr Loss
Brief: Panacea Biotec Gets Shareholders' Nod For Reappointment Of Rajesh Jain As MD
Brief: Panacea Biotec Enters Into Agreement With Natco Pharma And Breckenridge Pharma
Brief: India's Panacea Biotec June-Qtr Net Loss Narrows
India's Panacea Biotec rises on settlement deal with Celgene
Brief: Panacea Biotec, Apotex Enters Into Settlement Agreement With Celgene Corp
Brief: Panacea Biotec Approves Elevation Of Rajesh Jain To Position Of MD